Pharma Pulse

Pharma news, minus the noise.

High-density pharmaceutical news intelligence for health and pharma professionals. We synthesize global pharma discourse into a 10-minute technical briefing delivered by 0700 ET.

AI Pharma Pulse

AI Pharma Pulse: GSK Nets $10.6B Lung Cancer Deal, FDA OKs First Oral PCSK9, Novartis $1.5B Myricx — July 23, 2026

[ ARCHIVE ]
Regulatory
FDA approves first drug for hepatitis delta virus

Historic first-in-class approval for bulevirtide; HDV affects ~15M patients co-infected with HBV globally.

Funding
NewLimit raises $435M to advance epigenetic reprogramming

Series B led by a16z Biohealth. Funds IND-enabling work for partial reprogramming candidates targeting age-related decline.

Read Full Briefing
Efficiency

AI-Curated Density

LLMs scan multiple sources to surface technical signals.

Precision

10-Minute Read

Information architecture optimized for rapid scanning. Bulleted updates with source links for deep dives.

Access

Open Intelligence

Zero cost, zero friction. We believe pharma industry transparency is a public utility for healthcare professionals.

ARCHIVE
2026-07-23AI Pharma Pulse: GSK Nets $10.6B Lung Cancer Deal, FDA OKs First Oral PCSK9, Novartis $1.5B Myricx — July 23, 20262026-07-22AI Pharma Pulse: FDA approves first oral PCSK9, Gene & Cell therapies, and $1.5B ADC wave — July 22, 20262026-07-20AI Pharma Pulse: Lilly’s $2.8B Psychedelics Bet, Lipfendra Oral PCSK9 Approval, and GSK Cough Failure — July 20, 20262026-07-19AI Pharma Pulse: Merck’s PCSK9 Pill, Eli Lilly’s Psychedelic Bet, and GSK’s Cough Collapse — July 19, 20262026-07-17AI Pharma Pulse: Lilly’s $2.8B Psychedelic Bet Shakes Up Mental‑Health Market — July 17, 20262026-07-16AI Pharma Pulse: Merck’s ADC Breakthrough, Celcuity’s Breast Cancer Approval, and Chai’s $400M AI Funding — July 16, 20262026-07-15AI Pharma Pulse: FDA Approves First SCD Gene Therapy, and Spero’s $1.1B Antibody Deal — July 15, 20262026-07-14AI Pharma Pulse: FDA Greenlights Gene Therapy for Sickle Cell, GSK’s ADC Wins, and Roche Halts Huntington Programs — July 14, 20262026-07-13AI Pharma Pulse: FDA greenlights first sickle‑cell gene therapy, GSK’s ADC win, and Roche halts Huntington programs — July 13, 20262026-07-12AI Pharma Pulse: FDA greenlights first sickle‑cell gene therapy, GSK’s ADC win, and AstraZeneca heart‑failure flop — July 12, 20262026-07-11AI Pharma Pulse: FDA greenlights gene therapy Casgevy, pembrolizumab combo, and TREGZI — three first‑in‑class approvals — July 11, 20262026-07-10AI Pharma Pulse: Vertex’s $10B Crinetics Grab, Casgevy Gene‑Therapy Approval, GSK $700M Alzheimer Loss, and Kailera Obesity Win — July 10, 20262026-07-09AI Pharma Pulse: Vertex’s $10B Crinetics Bet Signals Giant Push into Endocrine Market — July 9, 20262026-07-08AI Pharma Pulse: FDA OKs First Gene Therapy for Kids, Vertex Splashes $10B on Crinetics, Kailera Hits GLP‑1 Phase 3 — July 8, 20262026-07-07AI Pharma Pulse: Roche KRAS Lung Cancer Win Beats Amgen and BMS — July 7, 20262026-07-06AI Pharma Pulse: FDA Approves First Treg Cell Therapy, Roche KRAS Beats Amgen, Novartis $1.1B ADC Deal — July 6, 20262026-07-05AI Pharma Pulse: Roche’s KRAS Win Beats Amgen and BMS, plus Three FDA Approvals for Gene Therapies — July 5, 20262026-07-04AI Pharma Pulse: Roche’s KRAS Win, China’s First Solid‑Tumor CAR‑T, and a $600M AI Deal — July 4, 20262026-07-03AI Pharma Pulse: Roche’s KRAS Win Beats Amgen, BMS, and Fuels New Competition — July 3, 20262026-07-02AI Pharma Pulse: Merck KGaA’s $11B buyout, China’s solid‑tumor CAR‑T approval, and Insilico‑Takeda $600M AI pact — July 2, 20262026-06-30AI Pharma Pulse: Ipsen’s $1.7B Kartos Grab, Dexcom’s OTC CGM, and a Sobi Gout Setback — June 30, 20262026-06-29AI Pharma Pulse: FDA Clears Hepcludex, Otsuka’s ADHD Win, and AstraZeneca Bone Data — June 29, 20262026-06-28AI Pharma Pulse: FDA Approves First HDV Therapy, Hepcludex, Opening $200M Market — June 28, 20262026-06-27AI Pharma Pulse: Biogen cuts Apellis, HDV drug approved, and Tzield gains pediatric label — June 27, 20262026-06-26AI Pharma Pulse: FDA Clears First‑Line TNBC Boost, HDV Breakthrough, and Otsuka ADHD Win — June 26, 20262026-06-25AI Pharma Pulse: FDA greenlights sacituzumab, Otsuka ADHD win, and Boehringer AI deal — June 25, 20262026-06-21AI Pharma Pulse: Biogen’s $1B RayThera Grab, Moderna’s Flu Vote, Novocure’s Device Failure — June 21, 20262026-06-15AI Pharma Pulse: Lilly’s $2.3B Ajax Bet, HDV’s First Therapy, and Capivasertib Oncology Approval — June 15, 20262026-06-14AI Pharma Pulse: Lilly’s $2.3B JAK Bet, Novartis’ $12B Avidity Win, and First HDV Approval — June 14, 20262026-06-13AI Pharma Pulse: FDA Approves HDV Therapy, AstraZeneca Launches GLP‑1 Pill, and Sanofi’s Immune Drug Fails — June 13, 2026

Join countless others

The pharma briefing for people who want to stay sharp without the noise.